Real-time enrollment status for this her2-positive early-stage breast cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:47 AM UTC
| NCT Number | NCT07402473 |
| Recruiting Status | Recruiting |
| Condition | HER2-positive Early-stage Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 50 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Rutgers, The State University of New Jersey |
| Last Updated on CT.gov | April 23, 2026 (Apr 23, 2026) |
As of July 13, 2026: Clinical trial NCT07402473 is currently recruiting participants. This clinical trial study for her2-positive early-stage breast cancer is actively seeking new participants at 7 locations across the United States. The study is sponsored by Rutgers, The State University of New Jersey. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07402473 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07402473 was last updated Apr 23, 2026 (April 23, 2026). HelloStudys verifies this status automatically.